beta

AKBA

Akebia Therapeutics Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts.

Market Cap: 395 Million

Primary Exchange: NASDAQ/NMS (GLOBAL MARKET)

Website: akebia.com

Shares Outstanding: 160 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 2.60256475998671

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Ethical Flags

Longest drawdown: 2394 trading days

From: 2014-06-20 To: 2021-07-26

Lowest Point:

Akebia Therapeutics Launches AkebiaCares, an Enhanced Patient Access Program for People with Chronic Kidney Disease

via: Business Wire at 2019-06-11 03:30:00:000

AkebiaCares connects patients, caregivers and health care providers with resources and important information to support greater access to therapy Akebia Therapeutics, Inc. (Nasdaq: AKBA) a biopharmaceutical company focused on the development and commercialization of therapeutics for… read more...

Akebia Therapeutics Launches AkebiaCares, an Enhanced Patient Access Program for People with Chronic Kidney Disease

via: Business Wire at 2019-06-11 03:30:00:000

AkebiaCares connects patients, caregivers and health care providers with resources and important information to support greater access to therapy Akebia Therapeutics, Inc. (Nasdaq: AKBA) a biopharmaceutical company focused on the development and commercialization of therapeutics for… read more...

Akebia Therapeutics Launches AkebiaCares, an Enhanced Patient Access Program for People with Chronic Kidney Disease

via: Business Wire at 2019-06-11 03:30:00:000

AkebiaCares connects patients, caregivers and health care providers with resources and important information to support greater access to therapy Akebia Therapeutics, Inc. (Nasdaq: AKBA) a biopharmaceutical company focused on the development and commercialization of therapeutics for… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud